ENOV ENOVIS CORPORATION

Newsweek Names Enovis™ as One of America’s Greatest Workplaces for Diversity 2023

Newsweek Names Enovis™ as One of America’s Greatest Workplaces for Diversity 2023

Wilmington, DE, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Today, Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced that it has been recognized as one of America’s Greatest Workplaces for Diversity by Newsweek. The listing recognizes the best workplaces in the U.S. for their commitment to diversity, equity and inclusion (DEI) in the many categories of diversity.

Newsweek, in cooperation with Plant-A Insights Group, based its scoring on interviews with HR professionals, publicly available data, and an anonymous online survey of U.S. employees, yielding more than 350,000 company reviews to determine the results of the 2023 list.

“Research continually demonstrates that companies with a commitment to a diverse, equitable and inclusive workplace see numerous benefits such as better business performance, increased employee engagement, and an improved ability to attract and retain top talent,” explained Enovis Chief Human Resources Officer Patty Lang. “At Enovis, we value our diverse employee base and encourage our team members to bring individual ideas and perspectives to the table as we know these differences make us stronger. It is an honor to receive this recognition from a well-respected publication like Newsweek.”

To join one of America’s greatest workplaces for diversity, please click to view current career opportunities at Enovis.



About Enovis

Enovis Corporation (NYSE: ENOV) is an innovation-driven, medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services, and integrated technologies fuels active lifestyles in orthopedics and beyond. For more information about Enovis, please visit .



Katie Sweet, Communications
  
EN
27/02/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ENOVIS CORPORATION

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: December 6, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Enovis Announces Third Quarter 2025 Results

Enovis Announces Third Quarter 2025 Results Diversified growth platform delivers third-quarter sales growth of 9% on a reported basis, 7% organically Third-quarter Reconstructive sales grew 12% year-over-year on a reported basis, 9% organically October divestiture of Diabetic Footcare business unit from P&R for total proceeds of up to $60 million Raising full-year 2025 adjusted EBITDA and adjusted EPS guidance Dallas, TX, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, today annou...

 PRESS RELEASE

Enovis announces webcast and conference call for Third Quarter 2025 Re...

Enovis announces webcast and conference call for Third Quarter 2025 Results and participation in upcoming investor conferences Dallas, TX, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, announced today it will host an investor conference call and live webcast to discuss its third quarter 2025 financial results on Thursday, November 6th, 2025, at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. A presentation related to the call, as well as a webcast, wi...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch